S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q1 2024

Deep Track Capital

Periodo: Q1 2024 · Depositato: 2024-05-15
Vedi su SEC EDGAR
AUM
$3.49B
Valore totale del portafoglio
Posizioni
66
Titoli dichiarati
Prima Posizione
SWTX
4.9% $171.3M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2024-05-15) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SWTXSPRINGWORKS THERAPEUTICS INC$171.3M4.91%
4.9%
AMGNAMGEN INC$156.4M4.48%$264.32$374.15+41.5%
4.5%
APGEAPOGEE THERAPEUTICS INC$154.4M4.42%$65.05$132.91+104.3%
4.4%
INSMINSMED INC$129.8M3.72%$26.72$111.60+317.7%
3.7%
DYNDYNE THERAPEUTICS INC$129.3M3.70%$28.00$23.07-17.6%
3.7%
ALNYALNYLAM PHARMACEUTICALS INC$124.4M3.56%$153.33$312.78+104.0%
3.6%
GHGUARDANT HEALTH INC$123.8M3.55%$20.25$167.98+729.5%
3.5%
ARGXARGENX SE$118.1M3.38%$397.33$939.68+136.5%
3.4%
NTLAINTELLIA THERAPEUTICS INC$115.8M3.32%$27.22$17.56-35.5%
3.3%
OCULOCULAR THERAPEUTIX INC$115.8M3.32%$8.69$9.64+10.9%
3.3%
DVAXDYNAVAX TECHNOLOGIES CORP$113.5M3.25%
3.3%
AXSMAXSOME THERAPEUTICS INC$104.1M2.98%$76.99$244.31+217.3%
3.0%
ITCIINTRA-CELLULAR THERAPIES INC$103.8M2.97%
3.0%
GERNGERON CORP$100.7M2.88%$3.17$1.36-57.1%
2.9%
AUTLAUTOLUS THERAPEUTICS PLC$97.4M2.79%$5.68$1.58-72.2%
2.8%
FDMT4D MOLECULAR THERAPEUTICS IN$96.7M2.77%$30.01$13.00-56.7%
2.8%
ALKSALKERMES PLC$94.7M2.71%$27.24$54.58+100.4%
2.7%
BCYCBICYCLE THERAPEUTICS PLC$86.9M2.49%$24.25$4.35-82.1%
2.5%
PLRXPLIANT THERAPEUTICS INC$85.7M2.45%$14.81$1.17-92.1%
2.5%
MNMDMIND MEDICINE MINDMED INC$62.7M1.80%
1.8%
ABVXABIVAX SA$61.5M1.76%$13.97$144.65+935.4%
1.8%
VRDNVIRIDIAN THERAPEUTICS INC$60.5M1.73%$17.26$19.40+12.4%
1.7%
IONSIONIS PHARMACEUTICALS INC$59.5M1.71%$43.94$81.80+86.2%
1.7%
APLSAPELLIS PHARMACEUTICALS INC$58.8M1.68%$59.71
1.7%
ANIPANI PHARMACEUTICALS INC$56.8M1.63%$67.87$86.03+26.8%
1.6%
TVTXTRAVERE THERAPEUTICS INC$56.8M1.63%$7.31$56.92+678.7%
1.6%
VRNAVERONA PHARMA PLC$51.3M1.47%
1.5%
KYMRKYMERA THERAPEUTICS INC$50.7M1.45%$39.42$113.51+187.9%
1.4%
IVVDINVIVYD INC$48.6M1.39%$4.25$0.89-79.1%
1.4%
SYRESPYRE THERAPEUTICS INC$46.0M1.32%$37.00$86.63+134.1%
1.3%

Attività Trimestre su Trimestre

Q1 2024 vs. Q4 2023

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
AMGNAMGEN INC$156.4M+41.5%
ALNYALNYLAM PHARMACEUTICALS INC$124.4M+104.0%
MNMDMIND MEDICINE MINDMED INC$62.7M
APLSAPELLIS PHARMACEUTICALS INC$58.8M
KYMRKYMERA THERAPEUTICS INC$50.7M+187.9%
IVVDINVIVYD INC$48.6M-79.1%
FATEFATE THERAPEUTICS INC$40.9M
ENGNENGENE HOLDINGS INC$38.1M

Posizioni Chiuse (8)

TickerEmittenteNozionale
CYTKCYTOKINETICS INC$112.5M
AMAMAMBRX BIOPHARMA INC$52.8M
SRPTSAREPTA THERAPEUTICS INC$48.2M
RAPTRAPT THERAPEUTICS INC$44.6M
ACLXARCELLX INC$40.3M
ORTXORCHARD THERAPEUTICS PLC$33.6M
EWTXEDGEWISE THERAPEUTICS INC$27.8M
CYTKCYTOKINETICS INC$24.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
DYNDYNE THERAPEUTICS INC$102.7M+127.8%-17.6%
ALLKALLAKOS INC$-0.6M+99.1%
NTLAINTELLIA THERAPEUTICS INC$47.2M+87.1%-35.5%
OLMAOLEMA PHARMACEUTICALS INC$9.4M+67.0%
OCULOCULAR THERAPEUTIX INC$74.6M+37.8%+10.9%
ANIPANI PHARMACEUTICALS INC$23.7M+37.0%+26.8%
FDMT4D MOLECULAR THERAPEUTICS IN$50.4M+32.8%-56.7%
AXSMAXSOME THERAPEUTICS INC$24.5M+30.5%+217.3%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ITCIPUTINTRA-CELLULAR THERAPIES INC$-131.1M-91.2%
GPCRSTRUCTURE THERAPEUTICS INC$-10.5M-86.6%
ANABANAPTYSBIO INC$-31.7M-74.0%
IMVTIMMUNOVANT INC$-26.2M-50.7%
RLMDRELMADA THERAPEUTICS INC$-2.7M-39.3%
NUVLNUVALENT INC$-12.5M-39.0%
SYRESPYRE THERAPEUTICS INC$4.0M-37.9%+134.1%
SRRKSCHOLAR ROCK HLDG CORP$-7.0M-32.8%
Torna agli Hedge Fund